Malnutrition in patients with chronic GVHD

Bone Marrow Transplantation

Volumn 49, Issue 10, 2014, Pages 1300-1306

  Bassim, C W ^a   Fassil, H ^b   Dobbin, M ^c   Steinberg, S M ^b   Baird, K ^b   Cole, K ^b   Joe, G ^c   Comis, L E ^c   Mitchell, S A ^b   Grkovic, L ^b,d   Edwards, D ^a   Mays, J W ^a   Cowen, E W ^b   Pulanic, D ^b,d   Williams, K M ^b   Gress, R E ^b   Pavletic, S Z ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BODY MASS; CHRONIC DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVALUATION STUDY; FEMALE; FUNCTIONAL STATUS ASSESSMENT; GASTROINTESTINAL GRAFT VERSUS HOST REACTION; GRAFT VERSUS HOST REACTION; HUMAN; LABORATORY TEST; LUNG GRAFT VERSUS HOST REACTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MOUTH GRAFT VERSUS HOST REACTION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PATIENT GENERATED SUBJECTIVE GLOBAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SURVIVAL; SYMPTOMATOLOGY; TREATMENT FAILURE; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; MORTALITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MALNUTRITION; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84926419341     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.145     Document Type: Article

References (31)

1. Ferrara J, Levine J, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
2. Syrjala K, Martin P, Lee S. Delivering care to long-term adult survivors of hematopoietic cell transplantation. J Clin Oncol 2012; 30: 3746-3751.
3. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
4. Jacobsohn D, Margolis J, Doherty J, Anders V, Vogelsang G. Weight loss and malnutrition in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 231-236.
5. Nixon DW, Heymsfield SB, Cohen AE, Kutner MH, Ansley J, Lawson DH. Protein-calorie undernutrition in hositalized cancer patients. Am J Med 1980; 68: 683-690.
6. Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR. Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 1995; 15: 461-468.
7. Kyle U, Chalandon Y, Miralbell R, Karsegard V, Hans D, Trombetti A et al. Longitudinal follow-up of body composition in hematopoietic stem cell transplant patinets. Bone Marrow Transplant 2005; 35: 1171-1177.
8. Gupta D, Vashi P, Lammersfeld C, Braun D. Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature. Ann Nutr Metab 2011; 59: 96-106.
9. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutritional tool in patients with cancer. Eur J Clin Nutr 2002; 56: 779-785.
10. Leuenberger M, Kurmann S, Stanga Z. Nutritional screening tools in daily clinical practice: the focus on cancer. Support Care Cancer 2010; S2: 17-27.
11. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant 2006; 12: 252-266.
12. Lee S, Cook E, Soiffer R, Antin J. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444-452.
13. Davidson M, Morton Nd. A Systematic review of the Human Activity Profile. Clin Rehabil 2007; 21: 151-162.
14. Ware J, Gandek B. Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol 1998; 51: 903-912.
15. McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357-368.
16. Mitchell S, Leidy N, Mooney K, Dudley W, Beck S, LaStayo P et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant 2010; 45: 762-769.
17. Pidala J, Kurland B, Chai X, Majhail N, Weisdorf D, Pavletic S et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the chronic GVHD consortium. Blood 2011; 117: 5651-4657.
18. Herzberg P, Heussner P, Mumm F, Horak M, Hilgendorf I, Harsdorf Sv et al. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16: 707-1717.
19. Mehta C, Patel N. A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 1983; 78: 427-434.
20. Agresti A. Categorical Data Analysis. John Wiley and Sons Inc: New York, NY, USA, 1990.
21. Grkovic L, Baird K, Steinberg S, Williams K, Pulanic D, Cowen E et al. Clinical laboratory markers of in flammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia 2012; 26: 633-643.
22. Grkovic L, Mitchell SA, Baird K, Steinberg SM, Cowen EW, Williams KM et al. Assessing the validity of the NIH response criteria for chronic graft-versus-host disease (cGVHD): consensus measures correlate with clinical outcomes. Blood. 2011; 118: Abstract 4074.
23. Roberts S, Thompson J. Graft-vs-host disease: nutrition therapy in a clinically challening condition. Nutr Clin Pract 2005; 20: 440-450.
24. Lenssen P, Sherry ME, Cheney CL, Nims JW, Sullivan KM, Stern JM et al. Prevalence of nutrition-related problems among long-term survivers of allogeneic marrow transplantation. J Am Diet Assoc 1990; 90: 835-842.
25. Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC. Oral graft-versus-host disease. Oral Dis 2008; 14: 396-412.
26. Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW et al. Salivary gland involvement in chronic graft-versus-host disease: Prevalence, clinical significance, and recommendations for evaluations. Biol Blood Marrow Transplant 2010; xxx: 1-8.
27. Fall-Dickson JM, Mitchell SA, Marden S, Ramsay ES, Guadagnini JP, Wu T et al. Oral symtom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 948-956.
28. Lenssen P. Hematopoietic cell transplantation: Contemporary Nutrition Support Practice. Saunders Co.: St. Louis, MO, USA, 2003.
29. Stosovic M, Naumovic R, Stanojevic M, Simic-Ogrizovic S, Jovanovic D, Djukanovic L. Could the level of serum albumin be a method for assessing malnutrition in hemodialysis patients? Nutr Clin Pract 2011; 26: 607-613.
30. Martin PJ, Inamoto Y, Carpenter PA, Lee SJ, Flowers ME. Treatment of chronic graft-versus-host disease: past, present and future. Korean J Hematol 2011; 46: 153-163.
31. Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006; 12: 491-505.